Evidence map›Paper›PMID 38111642›Full record

ArticleFrontiers in microbiology2023

Comparative analysis of human respiratory syncytial virus evolutionary patterns during the COVID-19 pandemic and pre-pandemic periods.

Chi-Yu Guo, Yu Zhang, Yu-Yue Zhang, Wei Zhao, Xiang-Lei Peng, Yan-Peng Zheng, Yuan-Hui Fu, Jie-Mei Yu, Jin-Sheng He

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Chi-Yu Guo *College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China.
Yu Zhang *College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China.
Yu-Yue Zhang *College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China.
Wei ZhaoCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China.
Xiang-Lei PengCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China.
Yan-Peng ZhengCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China.
Yuan-Hui FuCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China.
Jie-Mei YuCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China.
Jin-Sheng HeCollege of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing, China.
Beijing Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has resulted in the implementation of strict mitigation measures that have impacted the transmission dynamics of human respiratory syncytial virus (HRSV). The measures also have the potential to influence the evolutionary patterns of the virus. In this study, we conducted a comprehensive analysis comparing genomic variations and evolving characteristics of its neutralizing antigens, specifically F and G proteins, before and during the COVID-19 pandemic. Our findings showed that both HRSV A and B exhibited an overall chronological evolutionary pattern. For the sequences obtained during the pandemic period (2019-2022), we observed that the HRSV A distributed in A23 genotype, but formed into three subclusters; whereas the HRSV B sequences were relatively concentrated within genotype B6. Additionally, multiple positively selected sites were detected on F and G proteins but none were located at neutralizing antigenic sites of the F protein. Notably, amino acids within antigenic site III, IV, and V of F protein remained strictly conserved, while some substitutions occurred over time on antigenic site Ø, I, II and VIII; substitution S389P on antigenic site I of HRSV B occurred during the pandemic period with nearly 50% frequency. However, further analysis revealed no substitutions have altered the structural conformations of the antigenic sites, the vial antigenicity has not been changed. We inferred that the intensive public health interventions during the COVID-19 pandemic did not affect the evolutionary mode of HRSV.

Indexed as

antigenic siteevolutionary patternhuman respiratory syncytial viruspositive selectiontertiary structure

Identifiers

PMID38111642
PMCPMC10725919
OpenAlexW4389302025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.